The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

NorthStar Gaming to Host Q3 Earnings Webinar on...

November 21, 2024

Cardiex Receives TGA Approval for CONNEQT Pulse Device

June 2, 2025

McDermitt Project Fast-Tracked Under U.S. FAST-41 Initiative

April 22, 2025

Lobo Tiggre: Gold’s Bullish New Paradigm, Copper Timing...

March 11, 2025

Brent Cook: 2024 Looks Better for Gold, but...

November 19, 2023

Amazon Eyes Nuclear Energy Future with Two New...

October 18, 2024

LU7 Announces Strategic Partnership with Polyechnique Montréal

February 12, 2025

China Approves 11 Nuclear Reactors in US$31 Billion...

August 21, 2024

Mawson Finland CEO Ms. Noora Ahola Awarded as...

December 17, 2024

Taxes on Cryptocurrencies (Updated 2024)

January 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,458)
    • Investing (3,664)
    • Politics (4,922)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved